Thermo Fisher Scientific TMO North America — Consolidated revenues
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Thermo Fisher Scientific in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Thermo Fisher Scientific's north america — consolidated revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Thermo Fisher Scientific's north america — consolidated revenues?
- Thermo Fisher Scientific (TMO) reported north america — consolidated revenues of $5.71B in Q1 2026.
- How has Thermo Fisher Scientific's north america — consolidated revenues changed year-over-year?
- Thermo Fisher Scientific's north america — consolidated revenues increased by 3.5% year-over-year, from $5.51B to $5.71B.
- What is the long-term trend for Thermo Fisher Scientific's north america — consolidated revenues?
- Over 4 years (2021 to 2025), Thermo Fisher Scientific's north america — consolidated revenues has grown at a 4.0% compound annual growth rate (CAGR), from $19.66B to $23.03B.
- What does north america — consolidated revenues mean?
- The total amount of money earned from sales made within the North American market.
- How do you interpret north america — consolidated revenues?
- An increase indicates growing market share or higher demand for the company's offerings in North America, while a decrease may signal competitive pressure, economic headwinds, or reduced regional customer spending.
- How does north america — consolidated revenues compare across companies?
- Comparable to regional revenue reporting by other global life sciences and diagnostics firms, which often break out performance by major geographic theaters to highlight localized growth drivers.